Cargando…
Investigation of monoclonal antibody dimers in a final formulated drug by separation techniques coupled to native mass spectrometry
Therapeutic monoclonal antibodies (mAbs) are highly complex proteins that must be exhaustively characterized according to the regulatory authorities' recommendations. MAbs display micro-heterogeneity mainly due to their post-translational modifications, but also to their susceptibility to chemi...
Autores principales: | Rouby, G., Tran, N. T., Leblanc, Y., Taverna, M., Bihoreau, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531515/ https://www.ncbi.nlm.nih.gov/pubmed/32633190 http://dx.doi.org/10.1080/19420862.2020.1781743 |
Ejemplares similares
-
Coupling Anion Exchange Chromatography with Native
Mass Spectrometry for Charge Heterogeneity Characterization of Monoclonal
Antibodies
por: Liu, Anita P., et al.
Publicado: (2022) -
Charge variant native mass spectrometry benefits mass precision and dynamic range of monoclonal antibody intact mass analysis
por: Bailey, Aaron O., et al.
Publicado: (2018) -
Monitoring
Disassembly and Cargo Release of Phase-Separated
Peptide Coacervates with Native Mass Spectrometry
por: Cerrato, Carmine P., et al.
Publicado: (2023) -
Rapid characterization of biotherapeutic proteins by size-exclusion chromatography coupled to native mass spectrometry
por: Haberger, Markus, et al.
Publicado: (2015) -
Native Mass Spectrometry: What is in the Name?
por: Leney, Aneika C., et al.
Publicado: (2016)